Rosemary A. Crane

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
10 years
Director since
2023

10 years of board service in total across 3 boards, counting each seat separately. Longest: Certara Inc., 3 years.

Certara Inc. Director
3 years · Since 2023
3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 5, 2026 Teva Pharmaceutical Industries Limited Option exercise +14,492 — —
May 14, 2026 Certara Inc. Option exercise +15,757 — —
Jun 6, 2025 Teva Pharmaceutical Industries Limited Option exercise +9,632 — —
May 21, 2025 Certara Inc. Option exercise +11,928 — —
Jun 24, 2024 Tarsus Pharmaceuticals Inc. Option exercise +3,350 — —
Jun 15, 2024 Teva Pharmaceutical Industries Limited Option exercise +21,108 — —
May 21, 2024 Certara Inc. Option exercise +8,663 — —
Aug 4, 2023 Teva Pharmaceutical Industries Limited Option exercise +15,810 — —
Jun 16, 2023 Tarsus Pharmaceuticals Inc. Option exercise +2,000 — —
May 23, 2023 Certara Inc. Option exercise +9,324 — —

Questions about Rosemary A. Crane

What boards is Rosemary A. Crane on?

Rosemary A. Crane sits on the boards of Certara Inc., Tarsus Pharmaceuticals Inc. and Teva Pharmaceutical Industries Limited.

How long has Rosemary A. Crane served on boards?

Our records show at least 10 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.